Hysteroscopic sterilisation by tubal cannulation and placement of intrafallopian implants
Summary
The National Institute for Health and Clinical Excellence (NICE) has issued updated full guidance to the NHS in England, Wales, Scotland and Northern Ireland on hysteroscopic sterilisation by tubal cannulation and placement of intrafallopian implants
This guidance replaces previous guidance on hysteroscopic sterilisation by tubal cannulation and placement of intrafallopian implants (interventional procedure guidance 44).
Description
Sterilisation results in the inability to conceive children naturally. It is sometimes chosen as a method of birth control and is usually permanent. In women, hysteroscopic sterilisation by tubal cannulation and placement of intrafallopian implants is used to block the fallopian tubes, with the aim of preventing the eggs from reaching the womb and becoming fertilised. The procedure is performed by passing a small camera and tube (hysteroscope) through the vagina and cervix. A very small implant called a microinsert is placed into each fallopian tube using specialised narrow surgical instruments that are passed through the hysteroscope. The presence of the microinserts causes scar tissue to form in the fallopian tubes, which eventually blocks them.
OPCS code:
Details
Surgical procedures
Royal College of Obstetricians and Gynaecologists
Royal College of General Practitioners
Contact details:
(for general enquiries or comments)
(for procedure specific enquiries or comments)
ip@nice.org.uk
Interventional Procedures Programme
National Institute for Health and Clinical Excellence
MidCity Place
71 High Holborn
London
WC1V 6NA
